Dengue fever in humanized NOD/SCID mice

Dennis A. Bente, Michael W. Melkus, J. Victor Garcia, Rebeca Rico-Hesse

    Research output: Contribution to journalArticlepeer-review

    131 Scopus citations

    Abstract

    The increased transmission and geographic spread of dengue fever (DF) and its more severe presentation, dengue hemorrhagic fever (DHF), make it the most important mosquito-borne viral disease of humans (50 to 100 million infections/year) (World Health Organization, Fact sheet 117, 2002). There are no vaccines or treatment for DF or DHF because there are no animal or other models of human disease; even higher primates do not show symptoms after infection (W. F. Scherer, P. K. Russell, L. Rosen, J. Casals, and R. W. Dickerman, Am. J. Trop. Med. Hyg. 27:590-599, 1978). We demonstrate that nonobese diabetic/severely compromised immunodeficient (NOD/SCID) mice xenografted with human CD34+ cells develop clinical signs of DF as in humans (fever, rash, and thrombocytopenia), when infected in a manner mimicking mosquito transmission (dose and mode). These results suggest this is a valuable model with which to study pathogenesis and test antidengue products.

    Original languageEnglish (US)
    Pages (from-to)13797-13799
    Number of pages3
    JournalJournal of virology
    Volume79
    Issue number21
    DOIs
    StatePublished - Nov 2005

    ASJC Scopus subject areas

    • Microbiology
    • Immunology
    • Insect Science
    • Virology

    Fingerprint

    Dive into the research topics of 'Dengue fever in humanized NOD/SCID mice'. Together they form a unique fingerprint.

    Cite this